MGB Biopharma Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

MGB Biopharma General Information

Description

The company's anti-infective drugs are based on minor groove binder compounds to target and disrupt the function of deoxyribonucleic acid in disease-causing pathogens, enabling healthcare organizations to treat infected patients with the associated disease to get the proper care and work for the critical outcomes of initial and sustained cure.

Contact Information

Website
www.mgb-biopharma.com
Formerly Known As
York Place (No. 536)
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Willow House
  • Suite 1-2, Strathclyde Business Park, Kestrel View
  • Bellshill ML4 3PB
  • Scotland, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Willow House
  • Suite 1-2, Strathclyde Business Park, Kestrel View
  • Bellshill ML4 3PB
  • Scotland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MGB Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 30-Dec-2024 Completed Out of Business
9. Later Stage VC 03-Aug-2021 Completed Clinical Trials - Phase 2
8. Later Stage VC 30-Aug-2018 Completed Clinical Trials - Phase 2
7. Grant 14-Mar-2018 Completed Clinical Trials - Phase 2
6. Later Stage VC 26-Jul-2017 Completed Clinical Trials - Phase 2
5. Grant 09-Jun-2014 Completed Clinical Trials - Phase 2
4. Seed Round 28-Aug-2013 Completed Startup
3. Seed Round 13-Jan-2012 Completed Startup
2. Seed Round 17-May-2011 $1.72M $1.72M Completed Startup
1. University Spin-Out 01-Jul-2009 Completed Startup
To view MGB Biopharma’s complete valuation and funding history, request access »

MGB Biopharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 1,828,051 $0.000014 $0.25 $0.25 1x $0.25 4.67%
Ordinary 5,716,925 $0.000014 $0.25 $0.25 1x $0.25 14.59%
To view MGB Biopharma’s complete cap table history, request access »

MGB Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
The company's anti-infective drugs are based on minor groove binder compounds to target and disrupt the function of deox
Drug Discovery
Bellshill, United Kingdom
7 As of 2023

Philadelphia, PA
 

Indianapolis, IN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MGB Biopharma Competitors (41)

One of MGB Biopharma’s 41 competitors is Aro Biotherapeutics, a Venture Capital-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
Apexian Pharmaceuticals Venture Capital-Backed Indianapolis, IN
Apeptico Formerly VC-backed Vienna, Austria
Amal Therapeutics Formerly VC-backed Geneva, Switzerland
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
You’re viewing 5 of 41 competitors. Get the full list »

MGB Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MGB Biopharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
The University of Strathclyde University
To view MGB Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial

MGB Biopharma FAQs

  • When was MGB Biopharma founded?

    MGB Biopharma was founded in 2009.

  • Where is MGB Biopharma headquartered?

    MGB Biopharma is headquartered in Bellshill, United Kingdom.

  • What is the size of MGB Biopharma?

    MGB Biopharma has 7 total employees.

  • What industry is MGB Biopharma in?

    MGB Biopharma’s primary industry is Drug Discovery.

  • Is MGB Biopharma a private or public company?

    MGB Biopharma is a Private company.

  • What is MGB Biopharma’s current revenue?

    The current revenue for MGB Biopharma is .

  • How much funding has MGB Biopharma raised over time?

    MGB Biopharma has raised $10.7M.

  • Who are MGB Biopharma’s investors?

    The University of Strathclyde has invested in MGB Biopharma.

  • Who are MGB Biopharma’s competitors?

    Aro Biotherapeutics, Apexian Pharmaceuticals, Apeptico, Amal Therapeutics, and NovaBiotics are some of the 41 competitors of MGB Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process